Cyclospora and Cyclosporiasis: Symptoms, Treatment, and Rebuilding Your Gut After the Parasite

What is cyclosporiasis?

Cyclosporiasis is the infection caused by Cyclospora cayetanensis, a single-celled coccidian parasite that lives in the lining of the small intestine. Humans are its only known host. You cannot catch it directly from another sick person the way you catch a stomach bug: the parasite is shed in stool in an immature, non-infectious form and needs one to two weeks in the environment to become infectious. That single biological fact shapes everything about how the illness spreads — through contaminated food and water, not hand-to-hand.^1,7

It has been a nationally notifiable disease in the United States since 1999, and the CDC runs active surveillance every year.⁵

What are the symptoms of cyclosporiasis?

The hallmark is profuse, watery diarrhea that won't quit. Alongside it, people typically report:

• Loss of appetite and noticeable weight loss
• Marked fatigue
• Stomach cramps, bloating, nausea, and gas
• Low-grade fever and body aches

The incubation period is about a week (median ~7 days) from exposure to first symptoms. Left untreated, cyclosporiasis is characteristically relapsing and remitting — you feel better, then it returns — and can drag on for weeks to months. People with weakened immune systems can have especially severe, prolonged illness.^1,2

How do you get cyclospora? Is cyclosporiasis contagious?

You get it by swallowing food or water contaminated with the parasite — classically imported fresh produce. U.S. outbreaks have repeatedly been traced to cilantro, basil, raspberries, blackberries, snow peas, mesclun, and bagged salad mixes. Cases cluster hard in spring and summer: in one national surveillance window, roughly 93% of domestically acquired cases occurred between May and August.⁵

Is it contagious person-to-person? Essentially no. Because freshly passed oocysts take days to become infectious, you can't pass cyclosporiasis directly to someone by contact — a meaningful difference from norovirus or C. difficile.¹

Why a routine stool test can miss Cyclospora

A standard ova-and-parasite (O&P) exam does not reliably find Cyclospora. The organism has to be looked for on purpose — with modified acid-fast staining, UV autofluorescence microscopy, or a molecular PCR "GI panel." Shedding is also intermittent, so a single negative stool doesn't rule it out; clinicians often collect several specimens over about ten days.² If you've had weeks of unexplained watery diarrhea after eating fresh produce, this is worth raising with your doctor specifically.

How is cyclosporiasis treated?

The evidence-based cure is antibiotic, not herbal or probiotic. First-line treatment is trimethoprim-sulfamethoxazole (TMP-SMX, or co-trimoxazole), typically for 7–10 days. Randomized controlled trials support it: co-trimoxazole cleared infection where placebo did not,⁴ and it outperformed ciprofloxacin in immunocompromised patients (~95% vs ~70% clearance).³ For people with a sulfa allergy, ciprofloxacin or nitazoxanide are alternatives, but the evidence behind them is weaker — treat them as fallbacks, not equals.^2,3

To be completely clear: there is no evidence that probiotics treat, shorten, or cure cyclosporiasis. If you suspect it, see a clinician for diagnosis and antibiotics.^1,2

What the parasite — and the antibiotics — do to your gut microbiome

Here is the part that gets overlooked. Beating the parasite is step one; your gut ecosystem is the collateral. A parasitic infection itself reshapes the microbial community — Giardia, a related protozoan, drives measurable loss of commensal diversity throughout the gut.⁹ Then the treatment adds its own hit: antibiotics rapidly cut gut microbial diversity within days, and recovery is substantial but incomplete and highly individual — some beneficial species stay missing for months, and occasionally far longer.^10,11,12

The specific gut footprint of TMP-SMX is less studied than that of broad-spectrum drugs, and looks more like a shift in the "resistome" than a diversity collapse¹³ — but the broader lesson holds: an infection plus a course of antibiotics leaves your microbiome in a diminished, individual state that doesn't always snap back on its own.

The long tail: post-infectious IBS after a parasite

This is the strongest reason to take gut recovery seriously. A large meta-analysis of more than 21,000 people found that acute infectious gastroenteritis raised the risk of developing irritable bowel syndrome (IBS) more than fourfold within a year. And the risk depended on the culprit: after a protozoal/parasitic infection, 41.9% went on to develop IBS — versus 13.8% after a bacterial one.¹⁴ Real-world protozoal cohorts back this up: six years after a waterborne Giardia outbreak in Bergen, Norway, roughly 39% of those infected still had IBS.¹⁵

There isn't a long-term dataset for Cyclospora specifically, so this is an extrapolation from its protozoal cousins — but it's a well-founded one, and it reframes recovery from "wait and hope" to "actively rebuild."

Can probiotics help you recover after cyclosporiasis?

For the infection itself, no — clearing the parasite is the antibiotic's job. But for recovery afterward, yes: this is exactly where probiotics and microbiome rebuilding earn their keep.

• They ease the antibiotic's side effects. Probiotics measurably reduce antibiotic-associated diarrhea — a large meta-analysis put the pooled relative risk at 0.58, with Saccharomyces boulardii around 0.47 — so they can smooth the treatment course itself.^16,17
• They feed the gut's own repair crew. Butyrate and other short-chain fatty acids made by beneficial microbes rebuild the intestinal barrier and calm inflammation^22,23 — and those butyrate-producers are exactly what a parasite and antibiotics deplete. Restoring them is the core of gut recovery.
• What you rebuild with matters. Not every probiotic helps equally: in one controlled study, a generic multi-strain product actually slowed the native microbiome's return after antibiotics, while a person's own microbiome-matched restoration worked in days.¹⁸ The lesson isn't "skip probiotics" — it's that a tested, personalized rebuild beats a random off-the-shelf blend.

So the honest, useful message is this: probiotics won't cure the parasite, but a deliberate, personalized microbiome rebuild is one of the best tools you have to recover from the depletion it leaves behind — and to lower the odds of the lingering post-infectious gut trouble that so often follows a parasite.

How sequencing can surface parasites like Cyclospora

Most gut tests only look at bacteria. Shotgun metagenomic sequencing reads all of the DNA in a stool sample — which means the same test that profiles your microbiome can also surface the genetic signatures of eukaryotic parasites. Researchers have recovered the Cyclospora cayetanensis genome directly from human stool,²⁴ and metagenomics has been shown to detect gut protozoa such as Entamoeba and Blastocystis as well as, or better than, microscopy.^25,26

An honest boundary. Metagenomic sequencing is a profiling and research tool — not an FDA-cleared diagnostic for cyclosporiasis. Low-abundance or intermittently shed parasites can be missed, and a clean read does not rule a parasite out. If a parasite signal appears, that's a flag to see a clinician for a validated test (acid-fast stain, UV, or a targeted PCR panel), not a diagnosis in itself. What sequencing does uniquely well is show the whole picture: the parasite signal and the diversity loss it leaves behind.

Flore's whole-genome sequencing reads your gut at this depth, and Flore Clinical brings that same read into a clinical, provider-guided setting — so a parasite like Cyclospora can be surfaced as part of a full-community microbiome survey rather than missed by a bacteria-only test.

Rebuilding your gut after cyclosporiasis

Once the parasite is treated and cleared, the goal shifts to restoring what the infection and antibiotics took. Because recovery is so individual, a generic one-size probiotic is a blunt instrument. The more precise approach is to measure, then rebuild: sequence the microbiome to see which beneficial, butyrate-producing communities are depleted, then match a formula to those specific gaps.

That's the model behind Flore Custom — a microbiome test that maps your gut, followed by a personalized formula built from the results, rather than a shelf probiotic chosen at random. After a parasite has thinned your gut ecosystem, rebuilding it deliberately — and confirming the recovery on a follow-up read — is the difference between hoping your microbiome comes back and knowing it did.

How to prevent cyclosporiasis

• Wash fresh produce thoroughly — though washing reduces, it doesn't guarantee removal of Cyclospora oocysts.
• Be aware of active outbreaks and CDC advisories, especially in spring and summer, and around imported herbs and berries.
• Follow safe water practices when traveling in areas with poor sanitation.
• If you develop prolonged watery diarrhea after eating fresh produce, ask your clinician to test specifically for Cyclospora — routine panels can miss it.

References

1. Almeria S, Cinar HN, Dubey JP. Cyclospora cayetanensis and Cyclosporiasis: An Update. Microorganisms. 2019;7(9):317. PMID 31487898.
2. Mathison BA, Pritt BS. Cyclosporiasis—Updates on Clinical Presentation, Pathology, Clinical Diagnosis, and Treatment. Microorganisms. 2021;9(9):1863. PMID 34576758.
3. Verdier RI, et al. Trimethoprim-sulfamethoxazole compared with ciprofloxacin for Cyclospora and Isospora in HIV: a randomized trial. Ann Intern Med. 2000;132(11):885–888. PMID 10836915.
4. Hoge CW, et al. Placebo-controlled trial of co-trimoxazole for Cyclospora infections. Lancet. 1995;345(8951):691–693. PMID 7885125.
5. Casillas SM, Bennett C, Straily A. Cyclosporiasis Surveillance — United States, 2011–2015. MMWR Surveill Summ. 2019;68(3):1–16. PMID 31002104.
6. CDC. DPDx: Cyclosporiasis (life cycle / sporulation). cdc.gov/dpdx/cyclosporiasis.
7. Barash NR, et al. Giardia Alters Commensal Microbial Diversity throughout the Gut. Infect Immun. 2017;85(6). PMID 28396324.
8. Dethlefsen L, et al. Pervasive effects of an antibiotic on the human gut microbiota. PLoS Biol. 2008. PMID 19018661.
9. Dethlefsen L, Relman DA. Incomplete recovery of the gut microbiota after repeated antibiotics. PNAS. 2011. PMID 20847294.
10. Palleja A, et al. Recovery of gut microbiota of healthy adults following antibiotic exposure. Nat Microbiol. 2018. PMID 30349083.
11. D'Souza AW, et al. Cotrimoxazole prophylaxis and the infant gut resistome/microbiome. Clin Infect Dis. 2020. PMID 31832638.
12. Klem F, et al. Prevalence, Risk Factors, and Outcomes of IBS After Infectious Enteritis: Systematic Review and Meta-analysis. Gastroenterology. 2017. PMID 28069350.
13. Hanevik K, et al. IBS and chronic fatigue 6 years after Giardia infection: controlled cohort. Clin Infect Dis. 2014. PMID 25115874.
14. Hempel S, et al. Probiotics for antibiotic-associated diarrhea: systematic review and meta-analysis. JAMA. 2012. PMID 22570464.
15. Szajewska H, Kołodziej M. Saccharomyces boulardii for antibiotic-associated diarrhoea: meta-analysis. Aliment Pharmacol Ther. 2015. PMID 26216624.
16. Suez J, et al. Post-antibiotic gut microbiome reconstitution is impaired by probiotics and improved by autologous FMT. Cell. 2018. PMID 30193113.
17. Besirbellioglu BA, et al. Saccharomyces boulardii and infection due to Giardia lamblia. Scand J Infect Dis. 2006. PMID 16798698.
18. Sindhu KN, et al. Lactobacillus rhamnosus GG in acute gastroenteritis: permeability RCT. Clin Infect Dis. 2014. PMID 24501384.
19. Noor Z, et al. Nitazoxanide and probiotic in childhood cryptosporidiosis. Am J Trop Med Hyg. 2025. PMID 39933176.
20. Peng L, et al. Butyrate enhances the intestinal barrier via AMPK-driven tight-junction assembly. J Nutr. 2009. PMID 19625695.
21. Kelly CJ, et al. Microbiota-derived SCFAs and epithelial HIF augment barrier function. Cell Host Microbe. 2015. PMID 25865369.
22. Qvarnstrom Y, et al. Purification of Cyclospora cayetanensis oocysts from human stool for whole-genome sequencing. Gut Pathog. 2018. PMID 30337964.
23. Lokmer A, et al. Shotgun metagenomics for identification of gut protozoa across worldwide populations. PLoS One. 2019. PMID 30726303.
24. Beghini F, et al. Large-scale comparative metagenomics of Blastocystis in the human gut. ISME J. 2017;11(12):2848–2863. PMID 28837129.